Companies / Galectin Therapeutics Inc / Activity
Activity — Galectin Therapeutics Inc
8 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 6, 2026 | Lewis Joel CEO | Sell | Common Stock | $134.9K | -38K -4.33% | 832,592 1.26% of shares | medium |
| Jan 5, 2026 | Lewis Joel CEO | Sell | Common Stock | $108.3K | -28K -3.09% | 870,290 1.32% of shares | medium |
| Jan 2, 2026 | Lewis Joel CEO | Sell | Common Stock | $77.9K | -19K -2.03% | 898,021 1.36% of shares | low |
| Jan 2, 2026 | Lewis Joel CEO | Exercise | Common Stock | $0 | +84K +10.09% | 916,592 1.39% of shares | low |
| Jan 16, 2026 | Lewis Joel CEO | Grant | Restricted Stock Unit | — | +120K | 100,000 0.15% of shares | low |
| Jan 16, 2026 | Lewis Joel CEO | Grant | Stock option (right to buy) | — | +84K | 65,000 0.10% of shares | low |
| Jan 2, 2026 | Lewis Joel CEO | Exercise | Restricted Stock Unit | — | -84K -100.00% | 0 0.00% of shares | low |
| Jan 16, 2026 | Lewis Joel CEO | Grant | Stock option (right to buy) | — | +91K | 91,000 0.14% of shares | low |